FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Adult Use

  • Home
  •  | 
  • Tag Archives: "Adult Use"

Invictus Provides Update on German Partnership and EU-GMP Certification

Invictus Provides Update on German Partnership and EU-GMP Certification
The 90,000 square foot Phase 3 facility has an expected completion date of January 2019 and is fully funded as a result of the previously announced $25.5 million loan from ATB Financial. Approximately $10 million has been dedicated to the 90,000 square foot Phase 4 facility, which will commence construction upon completion of Phase 3.
Read more

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria’s Portfolio of Medical and Adult-Use Brands

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria’s Portfolio of Medical and Adult-Use Brands
Aphria Inc. ("Aphria" or the "Company") (TSX: APH andUS OTC: APHQF) and Rapid Dose Therapeutics Inc. ("RDT"), a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding Memorandum of Understanding ("MOU") related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world.
Read more